Drug Profile
NP 61
Alternative Names: NP 0361; NP-61Latest Information Update: 07 Mar 2013
Price :
$50
*
At a glance
- Originator Neuropharma
- Class Antidementias; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Amyloid beta-protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease